News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Meda AB (MDABF.PK) Acquires OTC Products From Norgine


11/11/2010 10:27:33 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) has acquired three well established OTC products from Norgine, a Dutch pharma company. The products are Pyralvex (relief of pain associated with e.g. aphthous ulcers), Spasmonal (treatment of for example Irritable Bowel Syndrome) and Waxsol (ear drops). The largest product is Pyralvex, which has a turnover of about 90 MSEK. Total annual sales for the products are about 190 MSEK and the majority of sales are generated in Europe. The purchase price is 540 MSEK which equals an EBITDA* multiple of about 5.

Read at BioSpace.com


comments powered by Disqus
Norgine
Meda AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES